148 related articles for article (PubMed ID: 22994215)
1. The future of stroke thrombolysis.
Hakim AM
Ann N Y Acad Sci; 2012 Sep; 1268():8-13. PubMed ID: 22994215
[TBL] [Abstract][Full Text] [Related]
2. Telestroke in South Carolina.
Lazaridis C; DeSantis SM; Jauch EC; Adams RJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):946-50. PubMed ID: 22196873
[TBL] [Abstract][Full Text] [Related]
3. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
California Acute Stroke Pilot Registry (CASPR) Investigators
Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
[TBL] [Abstract][Full Text] [Related]
4. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
[TBL] [Abstract][Full Text] [Related]
5. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
6. The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.
Kahn JH; Viereck J; Kase C; Jeerakathil T; Romero R; Mehta SD; Kociol R; Babikian V
J Emerg Med; 2005 Oct; 29(3):273-7. PubMed ID: 16183445
[TBL] [Abstract][Full Text] [Related]
7. The use and misuse of thrombolytic therapy within the Veterans Health Administration.
Keyhani S; Arling G; Williams LS; Ross JS; Ordin DL; Myers J; Tyndall G; Vogel B; Bravata DM
Med Care; 2012 Jan; 50(1):66-73. PubMed ID: 22182924
[TBL] [Abstract][Full Text] [Related]
8. Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study.
Messé SR; Kasner SE; Cucchiara BL; Demchuk A; Tanne D; Ouyang B; Levine SR;
J Stroke Cerebrovasc Dis; 2011; 20(3):236-40. PubMed ID: 20656508
[TBL] [Abstract][Full Text] [Related]
9. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
[TBL] [Abstract][Full Text] [Related]
10. Role of tissue plasminogen activator in acute ischemic stroke.
Hatcher MA; Starr JA
Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
[TBL] [Abstract][Full Text] [Related]
11. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
Li YH; Li MH; Zhao JG; Wang W
J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
[TBL] [Abstract][Full Text] [Related]
12. Treating acute ischemic stroke.
Fisher M; Bastan B
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
[TBL] [Abstract][Full Text] [Related]
13. R1--systemic thrombolysis in German stroke units--the experience from the German Stroke data bank.
Schenkel J; Weimar C; Knoll T; Haberl RL; Busse O; Hamann GF; Koennecke HC; Diener HC;
J Neurol; 2003 Mar; 250(3):320-4. PubMed ID: 12638023
[TBL] [Abstract][Full Text] [Related]
14. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
16. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
17. How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials.
Gorelick PB
Ann N Y Acad Sci; 2012 Sep; 1268():85-94. PubMed ID: 22994226
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of tissue plasminogen activator infusion for branch atheromatous disease.
Deguchi I; Hayashi T; Kato Y; Nagoya H; Ohe Y; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e168-72. PubMed ID: 23246192
[TBL] [Abstract][Full Text] [Related]
19. Does ICA occlusion frequently have intracerebral hemorrhage after IV tissue plasminogen activator therapy for ischemic stroke?
Kimura K; Sakai K; Iguchi Y; Shibazaki K; Sakamoto Y
Eur Neurol; 2011; 65(5):245-9. PubMed ID: 21464569
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]